Galectin Therapeutics Inc Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -10.39M-9.88M-12.09M-16.23M-13.90M-13.29M-23.46M-30.66M-39.33M-40.63M-47.63M
Depreciation and Depletion 0.01M0.00M
Share-based Compensation 1.94M3.25M2.79M3.79M4.07M1.10M4.45M1.68M1.80M2.08M2.87M2.26M2.45M
Gains from Investment Securities 1.17M0.16M1.50M0.40M0.04M0.53M-0.56M0.43M-0.59M
Asset Writedowns and Impairment 0.01M
Cash from Operations -3.10M-5.68M-7.50M-7.48M-12.43M-15.89M-10.18M-10.85M-20.60M-24.31M-31.06M-33.00M-41.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.04M0.04M0.04M0.03M0.03M0.04M
Amortization of Deferred Charges 0.01M0.34M0.09M0.09M0.28M0.41M0.70M1.10M
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.01M0.01M0.00M
Change in Working Capital
Change in Receivables 0.23M-0.23M
Change in Accured Expenses -0.14M1.27M-0.58M0.85M-0.78M-0.81M-1.09M1.00M2.54M3.69M4.24M2.67M4.44M
Other Working Capital Changes -0.29M0.03M0.06M0.04M0.34M-0.01M-0.02M0.36M1.59M-0.07M-0.10M0.09M0.08M
Investing Activities
Capital Expenditures 0.01M0.01M
Cash from Investing Activities -0.01M0.06M-0.40M
Financing Activities
Cash from Financing Activities 8.74M6.20M10.40M8.61M31.46M3.58M15.38M50.08M0.26M36.81M10.00M40.03M31.23M
Additional items
Change in Cash 5.64M0.51M2.97M1.12M18.64M-12.31M5.20M39.23M-20.34M12.51M-21.06M7.07M-10.54M
Beginning Cash Balance -5.64M-0.51M-2.97M-1.12M-18.64M12.31M-5.20M-39.23M20.34M-12.51M21.06M-7.07M10.54M
Free Cash Flow -3.10M-5.68M-7.50M-7.48M-12.43M-15.89M-10.18M-10.85M-20.60M-24.31M-31.06M-33.00M-41.80M
Net Cash Flow 5.64M0.51M2.97M1.12M18.64M-12.31M5.20M39.23M-20.34M12.51M-21.06M7.03M-10.57M